- Home
- OPCH vs STVN Comparison
OPCH vs STVN Comparison
Compare OPCH & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPCH
- STVN
- Stock Information
- Founded
- OPCH N/A
- STVN 1949
- Country
- OPCH United States
- STVN Italy
- Employees
- OPCH 7802
- STVN N/A
- Industry
- OPCH Medical/Nursing Services
- STVN Containers/Packaging
- Sector
- OPCH Health Care
- STVN Consumer Discretionary
- Exchange
- OPCH Nasdaq
- STVN Nasdaq
- Market Cap
- OPCH 5.3B
- STVN 6.2B
- IPO Year
- OPCH N/A
- STVN 2021
- Fundamental
- Price
- OPCH $31.44
- STVN $22.46
- Analyst Decision
- OPCH Buy
- STVN Buy
- Analyst Count
- OPCH 7
- STVN 6
- Target Price
- OPCH $32.14
- STVN $27.50
- AVG Volume (30 Days)
- OPCH 2.0M
- STVN 352.2K
- Earning Date
- OPCH 02-26-2025
- STVN 03-06-2025
- Dividend Yield
- OPCH N/A
- STVN 0.26%
- EPS Growth
- OPCH N/A
- STVN N/A
- EPS
- OPCH 1.19
- STVN 0.48
- Revenue
- OPCH $4,776,174,000.00
- STVN $1,220,254,294.00
- Revenue This Year
- OPCH $16.89
- STVN $3.01
- Revenue Next Year
- OPCH $6.40
- STVN $6.98
- P/E Ratio
- OPCH $26.08
- STVN $47.30
- Revenue Growth
- OPCH 13.58
- STVN 3.53
- 52 Week Low
- OPCH $21.39
- STVN $16.56
- 52 Week High
- OPCH $34.63
- STVN $34.73
- Technical
- Relative Strength Index (RSI)
- OPCH 73.12
- STVN 50.53
- Support Level
- OPCH $30.32
- STVN $20.72
- Resistance Level
- OPCH $31.69
- STVN $22.81
- Average True Range (ATR)
- OPCH 0.74
- STVN 1.12
- MACD
- OPCH -0.00
- STVN -0.01
- Stochastic Oscillator
- OPCH 80.30
- STVN 51.91
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
About STVN Stevanato Group S.p.A.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.